Multimodality Imaging of Uterine Cervical Malignancies

AJR Am J Roentgenol. 2020 Aug;215(2):292-304. doi: 10.2214/AJR.19.21941. Epub 2020 Jun 17.

Abstract

OBJECTIVE. In this article, we provide an updated review on the role of imaging in initial staging, treatment monitoring, and follow-up of cervical cancer with a focus on the role of MRI and FDG PET/CT. In addition, the 2018 International Federation of Gynecology and Obstetrics staging system and its implication on management of cervical cancer are explored. CONCLUSION. Imaging plays a major role in treatment planning and as a prognostic indicator in patients with cervical cancer. MRI and PET/CT have complementary roles: MRI is essential for the local staging of the primary tumor, and PET/CT is the most useful modality for detecting regional nodal and distant metastases.

Keywords: FDG PET/CT; FIGO; MRI; cervical cancer; staging.

Publication types

  • Review

MeSH terms

  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Magnetic Resonance Imaging*
  • Multimodal Imaging
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography* / methods
  • Radiopharmaceuticals*
  • Uterine Cervical Neoplasms / diagnostic imaging*
  • Uterine Cervical Neoplasms / pathology

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18